New reports on breast cancer treatments are coming to the fore. One report finds that too many women are still receiving total mastectomies, when lumpectomy would suffice. Other reports show that no time should be wasted between the diagnosis of breast cancer and surgical and chemotherapy treatments.
In August, Jimmy Carter was diagnosed with melanoma in his liver and brain. These lesions were addressed directly, he was put on Keytruda and now the former president is in remission. But since this new drug costs about $150,000 per year, we ask: Shouldn't we be talking about this?
Women diagnosed with cancer while pregnant have plenty to worry about. A new study may help reduce that burden, since it shows that typical cancer treatments may have no significant adverse effect on their fetus or newborn.
As if cancer patients don't have enough to worry about, they often must go through torture in the form of nausea and vomiting. Fortunately, a new drug called Varubi received FDA approval, and it's extremely effective in preventing these dreaded side effects of cancer chemotherapy.
In today's "you never know what is around the corner" department, a surprising story says that beta-blockers heart drugs that are used to lower blood pressure and slow the heart may have another use. That would be reducing the toll of ovarian cancer, which is one of the hardest types to treat.
A new study of combination intra-abdominal and intravenous chemotherapy for advanced ovarian cancer confirmed its significant benefits in terms of survival. So why aren t more Stage III and IV cancer patients getting this effective therapy? A combination of ignorance and greed seems likely.
One of the most difficult decisions a patient with late stage cancer has to make is whether or not to continue or use additional chemotherapy.
Here s a simple question with nothing even close to a simple answer: Do cancer drugs cost too much? ACSH s Dr. Josh Bloom, who has written frequently on this subject, including an op-ed the New York Post thinks that al too often they are. He says, There are obvious cases of recently approved cancer drugs that offer very little benefit in terms of either disease-free progression or extension of life. The annual cost for these drugs is roughly $100,000, but
The field of personalized medicine continues to explode. We have discussed the nascent approach of tailoring cancer treatments to specific gene mutations rather than the type of cancer. Although results have been mixed, many researchers believe that this is the future of cancer therapy, replacing the traditional scattershot approach.
Prostate cancer is the most common type of cancer in men. In 2015, there are expected to be 220,800 new cases of prostate cancer in the United States. Prostate cancer is the second leading cause of cancer death in American men (lung cancer is by far the leading cancer killer).
A major concern for the many thousands of women undergoing cancer chemotherapy most commonly breast cancer is hair loss, even though it s reversible over time. A new technique seems to help reduce the risk and severity: freezing caps.
When chemotherapy was first used in the 1940s, all of the drugs worked the same way by killing cells. The concept behind this was that, since cancer cells grow faster than non-cancerous cells, they would be selectively killed by the drug, leaving normal cells more or less unharmed.